SB216763, 25 mg

SB216763 is a potent selective and cell permeable glycogen synthase kinase-3 (GSK-3) inhibitor. It competes with ATP and potently inhibits the activity alpha and beta isozymes of GSK-3. GSK-3 is a serine/threonine protein kinase that is inhibited by an assortment of extracellular stimuli including insulin growth factors cell specification factors and cell adhesion.